Sales rose 30.91% to Rs 133.72 crore in the quarter ended December 2024
Asahi Songwon Colors has reported net profit of Rs 3.10 crore in the quarter ended December 2024 as against net loss of Rs 1.02 crore during the previous quarter ended December 2023.
Sales rose 30.91% to Rs 133.72 crore in the quarter ended December 2024 as against Rs 102.15 crore during the previous quarter ended December 2023.
Commenting on the Q3 & 9M FY25 performance, Gokul Jaykrishna, Joint Managing Director and CEO, said, “In the Azo business, while we remain focused on achieving profitability, we have encountered delays in the execution of our capital expenditure plans due to the postponement of equipment imports from China, which were affected by the Chinese New Year. Asa result, we now anticipate commencing commercial production from our ongoing debottlenecking initiatives in Q1 FY26, rather than Q4 FY25. Our primary objective for the Azo segment is to reach a PAT-positive level at the earliest opportunity, and we are confident that our strategic focus will yield results as market conditions improve. We have done better than the previous 9 months and are now EBITDA positive.
Regarding our API business, the situation remains stable as we continue to ramp up production at our intermediates plant in Chhatral. We expect to reap the benefits of our backward integration investments in the upcoming quarters. Our commitment to enhancing operational efficiencies remains steadfast, and we are optimistic that these efforts will contribute positively to our performance as we await an improved operating environment.”
Arjun G. Jaykrishna, Executive Director, commented, “The operating environment for our Phthalocyanine business segment continues to improve slowly. Despite the slow demand, we have done very well and are confident of doing well in the coming quarters.
We are leveraging our leadership position to perform better than our competitors in this challenging landscape. Our focus remains on enhancing internal efficiencies and optimizing our operations to navigate the current market conditions effectively.
We are confident that once the operating environment normalizes, we will be well-positioned to capitalize on improved market conditions, leading to enhanced profitability for our Phthalocyanine business. Until then, we are committed to refining our processes and maintaining operational excellence.”
Subscribe To Our Newsletter & Stay Updated